HDAC9 and prostate carcinoma: The results in Figure S3B, C showed that there were increasing acetylation status and HDAC activity in vincristine‐induced oral cancer resistant tumour KB/VCR and docetaxel‐induced prostate cancer DU145/Doc cells, but not in resistant H460/RT cells and EC109/CDDP compared to the paired cells.